Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy

Cancer Immunology, Immunotherapy

Volumn 63, Issue 8, 2014, Pages 835-845

  Park, Jungsun ^a   Li, Haiyan ^a,b   Zhang, Mingjun ^a,b   Lu, Yong ^a,b   Hong, Bangxing ^a,b   Zheng, Yuhuan ^a,b   He, Jin ^a   Yang, Jing ^a   Qian, Jianfei ^a,b   Yi, Qing ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer immunotherapy; Dendritic cells; IL 3; Survival; Th9 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; PROTEIN BCL XL; STAT5 PROTEIN; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; C57BL/6N MOUSE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FILTERS AND MEMBRANES; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA B16; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TH9 CELL; UPREGULATION;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL SURVIVAL; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-3; INTERLEUKIN-9; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84906791933     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-014-1557-4     Document Type: Article

References (30)

1. Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12(4):265-277. doi:10.1038/nrc3258
2. Heath WR, Carbone FR (2013) The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 14(10):978-985. doi:10.1038/ni.2680
3. Matthews KE, Qin JS, Yang J, Hermans IF, Palmowski MJ, Cerundolo V, Ronchese F (2007) Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses. J Immunol 179(9):5738-5747
4. Kamath AT, Pooley J, O'Keeffe MA, Vremec D, Zhan Y, Lew AM, D'Amico A, Wu L, Tough DF, Shortman K (2000) The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 165(12):6762-6770 (Pubitemid 32001141)
5. Park Y, Lee SW, Sung YC (2002) Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J Immunol 168(1):5-8 (Pubitemid 34014095)
6. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P (1998) Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188(11):2175-2180 (Pubitemid 28562533)
7. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180(4):1263-1272 (Pubitemid 24289600)
8. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y (2000) TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 191(3):495-502
9. Miga AJ, Masters SR, Durell BG, Gonzalez M, Jenkins MK, Maliszewski C, Kikutani H, Wade WF, Noelle RJ (2001) Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur J Immunol 31(3):959-965. doi:10.1002/1521-4141(200103)31:3〈959:AID-IMMU959〉3.0. CO;2-A
10. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, Kuchroo VK (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9(12):1347-1355. doi:10.1038/ni.1677
11. Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, Nguyen ET, Robertson MJ, Perumal NB, Tepper RS, Nutt SL, Kaplan MH (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11(6):527-534. doi:10.1038/ni.1867
12. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, Dehzad N, Becker M, Stassen M, Steinborn A, Lohoff M, Schild H, Schmitt E, Bopp T (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33(2):192-202. doi:10.1016/j.immuni.2010.07.014
13. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9(12):1341-1346. doi:10.1038/ni.1659
14. Lu Y, Hong S, Li H, Park J, Hong B, Wang L, Zheng Y, Liu Z, Xu J, He J, Yang J, Qian J, Yi Q (2012) Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122(11):4160-4171. doi:10.1172/JCI65459
15. Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, Jetten AM, Khoury SJ, Fuhlbrigge RC, Kuchroo VK, Clark RA, Kupper TS (2012) Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18(8):1248-1253. doi:10.1038/nm.2856
16. Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252(1):104-115. doi:10.1111/imr.12028
17. Soroosh P, Doherty TA (2009) Th9 and allergic disease. Immunology 127(4):450-458. doi:10.1111/j.1365-2567.2009.03114.x
18. Park JS, Sohn HJ, Park GS, Chung YJ, Kim TG (2011) Induction of antitumor immunity using dendritic cells electroporated with polo-like kinase 1 (Plk1) mRNA in murine tumor models. Cancer Sci 102(8):1448-1454. doi:10.1111/j.1349- 7006.2011.01974.x
19. Reddy EP, Korapati A, Chaturvedi P, Rane S (2000) IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 19(21):2532-2547. doi:10.1038/sj.onc.1203594 (Pubitemid 30339209)
20. Yen JJ, Yang-Yen HF (2006) Transcription factors mediating interleukin-3 survival signals. Vitam Horm 74:147-163. doi:10.1016/S0083-6729(06)74006-7
21. Wilhelm C, Turner JE, Van Snick J, Stockinger B (2012) The many lives of IL-9: a question of survival? Nat Immunol 13(7):637-641. doi:10.1038/ni.2303
22. Robb L (2007) Cytokine receptors and hematopoietic differentiation. Oncogene 26(47):6715-6723. doi:10.1038/sj.onc.1210756
23. Broughton SE, Dhagat U, Hercus TR, Nero TL, Grimbaldeston MA, Bonder CS, Lopez AF, Parker MW (2012) The GMCSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol Rev 250(1):277-302. doi:10.1111/j.1600-065X.2012.01164.x
24. Ebner S, Hofer S, Nguyen VA, Furhapter C, Herold M, Fritsch P, Heufler C, Romani N (2002) A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 168(12):6199-6207 (Pubitemid 34620039)
25. Buelens C, Bartholome EJ, Amraoui Z, Boutriaux M, Salmon I, Thielemans K, Willems F, Goldman M (2002) Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. Blood 99(3):993-998 (Pubitemid 34525563)
26. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, Briere F, de Waal Malefyt R, Liu YJ (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283(5405):1183-1186
27. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185(6):1101-1111 (Pubitemid 27136802)
28. Hou WS, Van Parijs L (2004) A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 5(6):583-589. doi:10.1038/ni1071
29. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S, Gouilleux F (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18(29):4191-4199. doi:10.1038/sj.onc.1202796 (Pubitemid 29377850)
30. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311(5764):1160-1164. doi:10.1126/science.1122545